Research Partnership was proud to present two posters at UEG Week in Vienna October 12-15th using insights from its syndicated research solutions Therapy Watch and Living With. The first investigated the profile of Crohn’s disease patients in the 3rd or 4th line of advanced treatment and the second asked to what extent physicians are cycling through more than one TNFi (tumor necrosis factor inhibitor) in Ulcerative Colitis (UC) treatment.
Jump to a slide with the slide dots.
Inizio Ignite brings together Research Partnership, Putnam, Vynamic, and STEM.
Read morePHLEX Summit 2025 reveals how early alignment, agile planning, real-world insights, and AI are reshaping pharma launch excellence.
Read moreInizio Engage CEO Jim Sage shares leadership insights and perspectives on the future of pharma in pharmaphorum’s “12 Questions” interview.
Read more